125 related articles for article (PubMed ID: 37748278)
1. Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?
Lu Z; Wei X; Tan L; Xiang B; Gong W
Eur J Surg Oncol; 2023 Nov; 49(11):107073. PubMed ID: 37748278
[TBL] [Abstract][Full Text] [Related]
2. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
3. Hepatic resection vs. transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria with portal hypertension.
Yang J; Yang JY; Yan LN; Wen TF; Li B; Wang WT
Dig Liver Dis; 2018 Jul; 50(7):713-719. PubMed ID: 29622387
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis.
Xia F; Zhang Q; Chen X; Zhang B; Ndhlovu E; Zhang M; Zhu P
Surg Endosc; 2022 Dec; 36(12):8992-9000. PubMed ID: 35920912
[TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
[TBL] [Abstract][Full Text] [Related]
6. Preoperative transarterial chemoembolization for barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the milan criteria: a propensity score matching analysis.
Guo C; Zou X; Hong Z; Sun J; Xiao W; Sun K; Li X; Shen Y; Liang T; Bai X
HPB (Oxford); 2021 Sep; 23(9):1427-1438. PubMed ID: 33715958
[TBL] [Abstract][Full Text] [Related]
7. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
[TBL] [Abstract][Full Text] [Related]
8. Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria.
Li C; Wen TF; Yan LN; Lu WS; Li B; Wang WT; Xu MQ; Yang JY
J Surg Res; 2017 Mar; 209():8-16. PubMed ID: 28032575
[TBL] [Abstract][Full Text] [Related]
9. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F
HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213
[TBL] [Abstract][Full Text] [Related]
10. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant portal hypertension (CSPH) on early-stage HCC following hepatectomy: What's the impact?
Xia F; Huang Z; Zhang Q; Ndhlovu E; Chen X; Zhang B; Zhu P
Eur J Surg Oncol; 2023 Apr; 49(4):771-779. PubMed ID: 36372619
[TBL] [Abstract][Full Text] [Related]
13. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
14. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
[TBL] [Abstract][Full Text] [Related]
15. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
17. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
He W; Zeng Q; Zheng Y; Chen M; Shen J; Qiu J; Chen M; Zou R; Liao Y; Li Q; Wu X; Li B; Yuan Y
BMC Cancer; 2015 Apr; 15():263. PubMed ID: 25886495
[TBL] [Abstract][Full Text] [Related]
18. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
[TBL] [Abstract][Full Text] [Related]
19. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].
Guo Z; Xiang B; Zhang J; Jiang J; Li L
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
